Dataset Information

Risk, Prediction and Prevention of Hereditary Breast Cancer - Large-Scale Genomic Studies in Times of Big and Smart Data.

ABSTRACT: Over the last two decades genetic testing for mutations in BRCA1 and BRCA2 has become standard of care for women and men who are at familial risk for breast or ovarian cancer. Currently, genetic testing more often also includes so-called panel genes, which are assumed to be moderate-risk genes for breast cancer. Recently, new large-scale studies provided more information about the risk estimation of those genes. The utilization of information on panel genes with regard to their association with the individual breast cancer risk might become part of future clinical practice. Furthermore, large efforts have been made to understand the influence of common genetic variants with a low impact on breast cancer risk. For this purpose, almost 450?000 individuals have been genotyped for almost 500?000 genetic variants in the OncoArray project. Based on first results it can be assumed that - together with previously identified common variants - more than 170 breast cancer risk single nucleotide polymorphisms can explain up to 18% of familial breast cancer risk. The knowledge about genetic and non-genetic risk factors and its implementation in clinical practice could especially be of use for individualized prevention. This includes an individualized risk prediction as well as the individualized selection of screening methods regarding imaging and possible lifestyle interventions. The aim of this review is to summarize the most recent developments in this area and to provide an overview on breast cancer risk genes, risk prediction models and their utilization for the individual patient.

SUBMITTER: Wunderle M

PROVIDER: S-EPMC5986564 | biostudies-literature | 2018 May

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Risk, Prediction and Prevention of Hereditary Breast Cancer - Large-Scale Genomic Studies in Times of Big and Smart Data.

Wunderle Marius M Olmes Gregor G Nabieva Naiba N Häberle Lothar L Jud Sebastian M SM Hein Alexander A Rauh Claudia C Hack Carolin C CC Erber Ramona R Ekici Arif B AB Hoyer Juliane J Vasileiou Georgia G Kraus Cornelia C Reis André A Reis André A Hartmann Arndt A Schulz-Wendtland Rüdiger R Lux Michael P MP Beckmann Matthias W MW Fasching Peter A PA

Geburtshilfe und Frauenheilkunde 20180501 5

Over the last two decades genetic testing for mutations in <i>BRCA1</i> and <i>BRCA2</i> has become standard of care for women and men who are at familial risk for breast or ovarian cancer. Currently, genetic testing more often also includes so-called panel genes, which are assumed to be moderate-risk genes for breast cancer. Recently, new large-scale studies provided more information about the risk estimation of those genes. The utilization of information on panel genes with regard to their ass ...[more]

PMID: 29880983

Similar Datasets

Project description:BackgroundFor marker effect models and genomic animal models, computational requirements increase with the number of loci and the number of genotyped individuals, respectively. In the latter case, the inverse genomic relationship matrix (GRM) is typically needed, which is computationally demanding to compute for large datasets. Thus, there is a great need for dimensionality-reduction methods that can analyze massive genomic data. For this purpose, we developed reduced-dimension singular value decomposition (SVD) based models for genomic prediction.MethodsFast SVD is performed by analyzing different chromosomes/genome segments in parallel and/or by restricting SVD to a limited core of genotyped individuals, producing chromosome- or segment-specific principal components (PC). Given a limited effective population size, nearly all the genetic variation can be effectively captured by a limited number of PC. Genomic prediction can then be performed either by PC ridge regression (PCRR) or by genomic animal models using an inverse GRM computed from the chosen PC (PCIG). In the latter case, computation of the inverse GRM will be feasible for any number of genotyped individuals and can be readily produced row- or element-wise.ResultsUsing simulated data, we show that PCRR and PCIG models, using chromosome-wise SVD of a core sample of individuals, are appropriate for genomic prediction in a larger population, and results in virtually identical predicted breeding values as the original full-dimension genomic model (r = 1.000). Compared with other algorithms (e.g. algorithm for proven and young animals, APY), the (chromosome-wise SVD-based) PCRR and PCIG models were more robust to size of the core sample, giving nearly identical results even down to 500 core individuals. The method was also successfully tested on a large multi-breed dataset.ConclusionsSVD can be used for dimensionality reduction of large genomic datasets. After SVD, genomic prediction using dense genomic data and many genotyped individuals can be done in a computationally efficient manner. Using this method, the resulting genomic estimated breeding values were virtually identical to those computed from a full-dimension genomic model.

Project description:MotivationOne of the major goals in large-scale genomic studies is to identify genes with a prognostic impact on time-to-event outcomes which provide insight into the disease process. With rapid developments in high-throughput genomic technologies in the past two decades, the scientific community is able to monitor the expression levels of tens of thousands of genes and proteins resulting in enormous datasets where the number of genomic features is far greater than the number of subjects. Methods based on univariate Cox regression are often used to select genomic features related to survival outcome; however, the Cox model assumes proportional hazards (PH), which is unlikely to hold for each feature. When applied to genomic features exhibiting some form of non-proportional hazards (NPH), these methods could lead to an under- or over-estimation of the effects. We propose a broad array of marginal screening techniques that aid in feature ranking and selection by accommodating various forms of NPH. First, we develop an approach based on Kullback-Leibler information divergence and the Yang-Prentice model that includes methods for the PH and proportional odds (PO) models as special cases. Next, we propose R2 measures for the PH and PO models that can be interpreted in terms of explained randomness. Lastly, we propose a generalized pseudo-R2 index that includes PH, PO, crossing hazards and crossing odds models as special cases and can be interpreted as the percentage of separability between subjects experiencing the event and not experiencing the event according to feature measurements.ResultsWe evaluate the performance of our measures using extensive simulation studies and publicly available datasets in cancer genomics. We demonstrate that the proposed methods successfully address the issue of NPH in genomic feature selection and outperform existing methods.Availability and implementationR code for the proposed methods is available at github.com/lburns27/Feature-Selection.Contactkarthik.devarajan@fccc.edu.Supplementary informationSupplementary data are available at Bioinformatics online.

Dataset Information

Risk, Prediction and Prevention of Hereditary Breast Cancer - Large-Scale Genomic Studies in Times of Big and Smart Data.

Publications

Risk, Prediction and Prevention of Hereditary Breast Cancer - Large-Scale Genomic Studies in Times of Big and Smart Data.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets